EyePoint Pharmaceuticals
EYPT
#5264
Rank
C$2.01 B
Marketcap
C$24.31
Share price
-1.46%
Change (1 day)
94.12%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.27 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has C$0.27 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

EyePoint Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.48 B36.7%
2023-12-31$C$0.35 B170.13%
2022-12-31$C$0.13 B-44.35%
2021-12-31$C$0.23 B893.95%
2020-12-31$C$23.64 M117.3%
2019-12-31$C$10.87 M
2018-06-30$C$15.36 M-11.29%
2017-06-30$C$17.32 M-35.97%
2016-06-30$C$27.05 M-7.2%
2015-06-30$C$29.15 M83.08%
2014-06-30$C$15.92 M96.73%
2013-06-30$C$8.09 M-41.69%
2012-06-30$C$13.88 M-61.52%
2011-06-30$C$36.07 M3.14%
2010-06-30$C$34.97 M29.32%
2009-06-30$C$27.04 M-11.72%
2008-06-30$C$30.63 M-65.4%
2007-06-30$C$88.56 M-38.63%
2006-06-30$C$0.14 B92.06%
2005-06-30$C$75.13 M111.28%
2004-06-30$C$35.55 M523.79%
2003-06-30$C$5.7 M
2001-06-30$C$6.92 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NRC Health
NRC
C$19.81 M-92.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-C$3.99 Million-101.44% Bahamas